• Monday,September 23,2024
gecos.fr
X

Current approved therapeutic strategies for IPF and LC treatment.

$ 19.50

4.7 (341) In stock

Share

Proceedings of the ISCT scientific signature series symposium

Nicotinic receptors in airway disease

Antonio Moretti's research works Università degli Studi di Modena e Reggio Emilia, Modena (UNIMO) and other places

Beatrice ARAMINI, MD PhD

Stem cell therapy for COVID-19 and other respiratory diseases

PDF) Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development

Georgina COLÓ, PhD, PhD, Biología del Cáncer

Georgina COLÓ, PhD, PhD, Biología del Cáncer

Frontiers Mitochondria in Focus: From Function to Therapeutic

Core fucosylation regulates alveolar epithelial cells senescence

Percentage of environmental exposure among studied patients with ChILD

Prevalence, risk factors, and impact of lung Cancer on outcomes of

Patient recruitment flow chart. Abbreviation: LC-IPF = lung cancer